Drugs in the Pipeline
Dapagliflozin Under Review for Chronic Kidney Disease
The FDA has granted Priority Review to dapagliflozin (Farxiga) for the treatment of new or worsening CKD.
Your search for esrd returned 32 results
Drugs in the Pipeline
Trial Investigating Dapagliflozin in CKD Meets All End Points
The multicenter, event-driven, double-blind, placebo-controlled trial compared the effect of dapagliflozin to placebo on renal outcomes and cardiovascular mortality in patients with CKD.
Drugs in the Pipeline
Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication
The designation was granted based on results from the phase 3 DAPA-CKD trial, which was stopped early due to “overwhelming efficacy”.
Clinical Charts
Influenza Antiviral Treatments
FDA-approved antiviral therapies for the treatment and prophylaxis of influenza.
SABCS 2021
Elacestrant Improved PFS in Metastatic Breast Cancer Progressing on CDK4/6 Therapy
Elacestrant showed a statistically significant and clinically meaningful progression-free survival improvement compared with standard of care.
Clinical Charts
Diabetes Treatments
Antidiabetic agents for the treatment of diabetes including maintenance and max doses.
Clinical Charts
Irritable Bowel Syndrome Treatments
Drug therapy for the treatment of irritable bowel syndrome (IBS).
SABCS 2021
Monitoring ESR1 Mutations May Optimize Treatment in Metastatic Breast Cancer
Monitoring bESR1mut enabled optimization of the endocrine therapy used with a CDK4/6 inhibitor.
Clinical Charts
Parkinsonism Treatments
Parkinson's drug treatment chart categorized by pharmacological class.
Clinical Charts
FDA-Approved Melanoma Treatments
FDA-approved drug therapies for cutaneous melanoma.
